Miglustat
CAS No. 72599-27-0
Miglustat( N-Butyldeoxynojirimycin | NB-DNJ | OGT918 )
Catalog No. M24736 CAS No. 72599-27-0
Miglustat is an alkylated product of imino sugar deoxynojirimycin.It is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 80 | In Stock |
|
| 10MG | 125 | In Stock |
|
| 25MG | 232 | In Stock |
|
| 50MG | 385 | In Stock |
|
| 100MG | 561 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMiglustat
-
NoteResearch use only, not for human use.
-
Brief DescriptionMiglustat is an alkylated product of imino sugar deoxynojirimycin.It is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1).
-
DescriptionMiglustat is an alkylated product of imino sugar deoxynojirimycin.It is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1).
-
In Vitro——
-
In VivoAnimal Model:NPC1?/? mice Dosage:0.2?mg/kg Administration:Oral administration; once Result:Was able to rescue synaptic plasticity deficits, to restore ERKs activation and to counteract hyperexcitability.
-
SynonymsN-Butyldeoxynojirimycin | NB-DNJ | OGT918
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number72599-27-0
-
Formula Weight219.28
-
Molecular FormulaC10H21NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO[C@H]1[C@H](O)[C@@H](CO)N(CCCC)C[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Abian, O., et al., Therapeutic strategies for Gaucher disease: miglustat (NB-DNJ) as a pharmacological chaperone for glucocerebrosidase and the different thermostability of velaglucerase alfa and imiglucerase. Mol Pharm, 2011. 8(6): p. 2390-7.
molnova catalog
related products
-
UNC 926 hydrochlorid...
UNC-926 inhibits L3MBTL1 (IC50: 3.9 μM). UNC-926 also exhibits a low micromolar affinity for L3MBTL3.
-
NLS-StAx-h
Wnt inhibitor (IC50 = 1.4 μM). Stapled peptide inhibitor of oncogenic Wnt signaling. Inhibits β-catenin-transcription factor interactions. Inhibits proliferation and migration of colorectal cancer cells. Cell permeable.
-
BRD0639
BRD0639 is a pioneering inhibitor targeting the interaction between PRMT5 and its substrate adaptor.
Cart
sales@molnova.com